C9orf72 and frontotemporal dementia: In particular, small molecules that stabilize G4s in telomere and C9orf72 have shown promise in inhibiting telomerase activity for cancer therapy and reducing the toxic effects of the repeat expansion in ALS/FTD models [27,28].